Lilly Cymbalta Detailing To Increase Double Digits In 2006
This article was originally published in The Pink Sheet Daily
The company hopes its neuroscience sales force reorganization and Cymbalta physician marketing program will drive antidepressant sales.
You may also be interested in...
Sales of Lilly’s antidepressant more than doubled in the first quarter.
The US FDA appears to have concerns about the device used to administer the vaccine.